| Title | Author(s) | Year | View Count |
 | EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin | Tong, ZT; Cai, MY; Wang, XG; Kong, LL; Mai, SJ; Liu, YH; Zhang, HB; Liao, YJ; Zheng, F; Zhu, W; Liu, TH; Bian, XW; Guan, XY; Lin, MC; Zeng, MS; Zeng, YX; Kung, HF; Xie, D | 2012 | 129 |
| Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition | Zhu, W; Cai, MY; Tong, ZT; Dong, SS; Mai, SJ; Liao, YJ; Bian, XW; Lin, MC; Kung, HF; Zeng, YX; Guan, XY; Xie, D | 2012 | 111 |
| Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation | Zhang, B; Qian, D; Ma, HH; Jin, R; Yang, PX; Cai, MY; Liu, YH; Liao, YJ; Deng, HX; Mai, SJ; Zhang, H; Zeng, YX; Lin, MC; Kung, HF; Xie, D; Huang, JJ | 2012 | 73 |
| The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 | Zheng, F; Liao, YJ; Cai, MY; Liu, YH; Liu, TH; Chen, SP; Bian, XW; Guan, XY; Lin, MC; Zeng, YX; Kung, HF; Xie, D | 2012 | 153 |
 | EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies | Cai, MY; Tong, ZT; Zheng, F; Liao, YJ; Wang, Y; Rao, HL; Chen, YC; Wu, QL; Liu, YH; Guan, XY; Lin, MC; Zeng, YX; Kung, HF; Xie, D | 2011 | 358 |
| EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β 1 and is a predictor of outcome in ovarian carcinoma patients | Rao, ZY; Cai, MY; Yang, GF; He, LR; Mai, SJ; Hua, WF; Liao, YJ; Deng, HX; Chen, YC; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 102 |
| Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis | Wang, Y; Liu, YH; Mai, SJ; He, LJ; Liao, YJ; Deng, HX; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 539 |
| High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy | He, LR; Liu, MZ; Li, BK; Jia, WH; Zhang, Y; Liao, YJ; Chen, YC; Zhang, LJ; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 454 |
| Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Zhang, LJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 158 |
| Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 183 |
| Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma | Wu, GQ; Xie, D; Yang, GF; Liao, YJ; Mai, SJ; Deng, HX; Sze, J; Guan, XY; Zeng, YX; Lin, MC; Kung, HF | 2009 | 246 |
| Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder | Luo, JH; Hua, WF; Rao, HL; Liao, YJ; Kung, HF; Zeng, YX; Guan, XY; Chen, W; Xie, D | 2009 | 152 |
|
